Live feed16:58:10·476dINSIDERFilingvia QuantisnowPresident, Research & Develop. Sethuraman Natarajan was granted 60,800 shares and covered exercise/tax liability with 6,138 shares, increasing direct ownership by 38% to 199,659 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TRDA· Entrada Therapeutics Inc.Health CareOriginal source